An oral Aujeszky's disease vaccine (YS-400) induces neutralizing antibody in pigs
Dong-Kun YANG; Ha-Hyun KIM; Sung-Suk CHOI; Bang-Hun HYUN; Jae-Young SONG.
Clinical and Experimental Vaccine Research
; : 132-137, 2016.
Artículo
en Inglés
| WPRIM | ID: wpr-176940
PURPOSE:
Aujeszky's disease (AD) is an economically important disease affecting both wild and domestic pigs of the species Sus scrofa. A previous study yielded serological evidence of AD in Korean wild boars, which could spread AD to other animals. A new Aujeszky's disease virus (ADV) bait vaccine is required to prevent AD outbreaks in swine. In the present study, we investigated the safety and immunogenicity of a gE-deleted marker vaccine, strain YS-400, in young domestic pigs. MATERIALS ANDMETHODS:
The YS-400 strain was propagated in Vero cells, and the trial ADV bait vaccine (a vaccine blister in a matrix including an attractant) was prepared. Pigs were orally immunized with the vaccine (2 mL, 10(7.5) TCID(50)/mL) delivered using a syringe or in the bait vaccine. The animals were observed for 9 weeks after vaccination, and immunogenicity was assessed using a virus neutralization (VN) test and enzyme linked immunosorbent assay.RESULTS:
The YS-400 strain was non-pathogenic to pigs when given orally and induced high VN titers (132-1128) 6 weeks post-administration. Of the pigs given the ADV bait vaccine twice or three times, 40% were seropositive by 2 weeks, and 100% were seropositive by 7 weeks after the first dose. Pigs that consumed the AD bait vaccine three times developed VN titers that were slightly higher than those of pigs given the vaccine twice.CONCLUSION:
Domestic pigs given the trial ADV bait vaccine exhibited no adverse effects and developed high VN titers against ADV, indicating that the YS-400 strain is safe and can prevent ADV infection in domestic pigs.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados